| Financial Year |
March 31 2023 |
| Monetary Funds |
10,685,522,741.56 |
| Held-for-trading Financial Assets |
25,000,000.00 |
| Notes Receivable |
200,989,490.98 |
| Accounts Receivable |
8,775,838,456.37 |
| Advances to Suppliers |
509,670,005.96 |
| Other Receivables |
859,307,741.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
8,675,663,823.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,984,567,747.38 |
| Other Current Assets |
497,087,870.12 |
| Total Current Assets |
34,665,896,244.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,671,370,096.63 |
| Long-term Equity Investment |
706,124,762.14 |
| Investment Properties |
231,159,283.29 |
| Fixed Assetes |
4,988,866,903.55 |
| Under-construction Projects |
904,416,490.49 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,505,582,325.95 |
| R&D expenses |
40,437,477.33 |
| Goodwill |
166,631,074.09 |
| Long-Term Deferred and Prepaid Expenses |
17,889,002.42 |
| Deferred Income Tax Assets |
933,021,340.64 |
| Other Non-Current Assets |
98,014,247.22 |
| Sub-Total of Non-Current Assets |
12,702,945,139.49 |
| Total Assets |
47,368,841,383.92 |
| Short-Term Loans |
7,318,241,665.05 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,670,565,927.48 |
| Accounts Payable |
6,386,575,217.33 |
| Accounts Received In Advance |
53,604,423.15 |
| Employee Compensation Payable |
266,477,267.54 |
| Taxes Payable |
372,172,814.37 |
| Interest Payable |
-- |
| Dividend Payable |
8,248,700.00 |
| Other payables |
2,262,435,461.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,338,552,078.13 |
| Other Current Liabilities |
237,879,480.81 |
| Sub-Total of Current Liabilities |
23,668,044,850.18 |
| Long-term Loans |
1,124,637,141.89 |
| Bonds Payable |
2,915,256,715.80 |
| Long-Term Accounts Payable |
262,526,495.43 |
| Special Payable |
-- |
| Estimatied Liabilities |
834,025,667.38 |
| Deferred Income Tax Liabilities |
56,506,481.18 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,107,414,793.17 |
| Total Liabilities |
29,775,459,643.35 |
| Paid-In Capital(Or Share Stock) |
1,951,261,261.00 |
| Capital Surplus |
6,020,121,267.99 |
| Surplus Reserve |
993,820,661.94 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
7,113,670,481.43 |
| Minority Stockholder's Interest |
1,438,323,489.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
16,155,058,251.50 |
| Owner's Equity（Stockholder's Equity） |
17,593,381,740.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
47,368,841,383.92 |
